Clean Science Investor Presentation – Q2 FY26 Business Update

Clean Science and Technology Limited has released its investor presentation for Q2 FY26. The presentation highlights the company’s resilient EBITDA margins due to a favorable product mix. Revenue stood at ₹245 crore in Q4 FY25 but decreased to ₹211 crore in Q2 FY26. The company focuses on innovation and sustainability with ongoing trials for performance chemicals and expansion activities.

Financial Performance Highlights

Clean Science and Technology Limited reported a revenue of ₹211 crore for Q2 FY26. The company maintained resilient EBITDA margins, driven by a favorable product mix. Here’s a look at key financial metrics:

  • Q3 FY24: Revenue ₹195 crore, EBITDA 33.6%
  • Q4 FY24: Revenue ₹225 crore, EBITDA 34.4%
  • Q1 FY25: Revenue ₹217 crore, EBITDA 34.1%
  • Q2 FY25: Revenue ₹228 crore, EBITDA 36.6%
  • Q3 FY25: Revenue ₹232 crore, EBITDA 35.7%
  • Q4 FY25: Revenue ₹245 crore, EBITDA 37.3%
  • Q1 FY26: Revenue ₹220 crore, EBITDA 32.5%
  • Q2 FY26: Revenue ₹211 crore, EBITDA 34.7%

P&L Overview

The Profit and Loss (P&L) statement provides insights into the company’s financial performance for Q2 FY26. Consolidated total revenue reached ₹245 crore, a 1% increase QoQ and a 3% increase YoY. Profit after tax (PAT) stood at ₹55 crore, reflecting a margin of 23.0%.

Business and Strategic Updates

Clean Science and Technology continues to focus on strategic initiatives, including ongoing chemical trials for performance chemicals and construction activities for performance chemical 2. The company remains committed to innovation and sustainability, which are integral to its operations.

Company Evolution & Future Growth

The company focuses on import substitution opportunities in India and seeks to add new export customers across different geographies. New product development remains a key area, with strategic investments aimed at developing speciality chemicals for various growing industries.

Clean Science & Technology aims to enhance its existing catalyst systems to further optimize yield and selectivity, expand product portfolio and develop products with high demand that are produced by limited manufacturers globally.

Source: BSE

Previous Article

Procter & Gamble Hygiene Q2 Sales Rise Slightly, Profit Stable

Next Article

Cholamandalam Investment and Finance Audited Results for Quarter and Half Year Ended September 30, 2025

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *